EMD-13336

Single-particle
3.8 Å
EMD-13336 Deposition: 05/08/2021
Map released: 26/01/2022
Last modified: 17/07/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-13336

focus refinement of soluble domain of adenylyl cyclase 9 in complex with Gs protein alpha subunit and MANT-GTP

EMD-13336

Single-particle
3.8 Å
EMD-13336 Deposition: 05/08/2021
Map released: 26/01/2022
Last modified: 17/07/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: Bos taurus
Sample: Adenylyl cyclase 9 bound to MANT-GTP
Fitted models: 7pdf (Avg. Q-score: 0.445)

Deposition Authors: Qi C , Korkhov VM
Structural basis of adenylyl cyclase 9 activation.
PUBMED: 35210418
DOI: doi:10.1038/s41467-022-28685-y
ISSN: 2041-1723
Abstract:
Adenylyl cyclase 9 (AC9) is a membrane-bound enzyme that converts ATP into cAMP. The enzyme is weakly activated by forskolin, fully activated by the G protein Gαs subunit and is autoinhibited by the AC9 C-terminus. Although our recent structural studies of the AC9-Gαs complex provided the framework for understanding AC9 autoinhibition, the conformational changes that AC9 undergoes in response to activator binding remains poorly understood. Here, we present the cryo-EM structures of AC9 in several distinct states: (i) AC9 bound to a nucleotide inhibitor MANT-GTP, (ii) bound to an artificial activator (DARPin C4) and MANT-GTP, (iii) bound to DARPin C4 and a nucleotide analogue ATPαS, (iv) bound to Gαs and MANT-GTP. The artificial activator DARPin C4 partially activates AC9 by binding at a site that overlaps with the Gαs binding site. Together with the previously observed occluded and forskolin-bound conformations, structural comparisons of AC9 in the four conformations described here show that secondary structure rearrangements in the region surrounding the forskolin binding site are essential for AC9 activation.